Fulcrum Therapeutics Statistics
Total Valuation
FULC has a market cap or net worth of $544.12 million. The enterprise value is $198.26 million.
Important Dates
The last earnings date was Tuesday, February 24, 2026, before market open.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FULC has 66.60 million shares outstanding. The number of shares has increased by 2.21% in one year.
| Current Share Class | 66.60M |
| Shares Outstanding | 66.60M |
| Shares Change (YoY) | +2.21% |
| Shares Change (QoQ) | +5.09% |
| Owned by Insiders (%) | 1.19% |
| Owned by Institutions (%) | 68.18% |
| Float | 43.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.40, with a Debt / Equity ratio of 0.02.
| Current Ratio | 27.40 |
| Quick Ratio | 27.08 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.30% and return on invested capital (ROIC) is -17.45%.
| Return on Equity (ROE) | -25.30% |
| Return on Assets (ROA) | -16.90% |
| Return on Invested Capital (ROIC) | -17.45% |
| Return on Capital Employed (ROCE) | -24.00% |
| Weighted Average Cost of Capital (WACC) | 22.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.36M |
| Employee Count | 55 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +151.39% in the last 52 weeks. The beta is 3.29, so FULC's price volatility has been higher than the market average.
| Beta (5Y) | 3.29 |
| 52-Week Price Change | +151.39% |
| 50-Day Moving Average | 10.26 |
| 200-Day Moving Average | 8.75 |
| Relative Strength Index (RSI) | 36.41 |
| Average Volume (20 Days) | 1,155,193 |
Short Selling Information
The latest short interest is 3.52 million, so 5.28% of the outstanding shares have been sold short.
| Short Interest | 3.52M |
| Short Previous Month | 3.87M |
| Short % of Shares Out | 5.28% |
| Short % of Float | 8.06% |
| Short Ratio (days to cover) | 5.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | -56.10M |
| Operating Income | -84.77M |
| Pretax Income | -74.88M |
| Net Income | -74.88M |
| EBITDA | -83.38M |
| EBIT | -84.77M |
| Earnings Per Share (EPS) | -$1.18 |
Full Income Statement Balance Sheet
The company has $352.31 million in cash and $6.44 million in debt, with a net cash position of $345.86 million or $5.19 per share.
| Cash & Cash Equivalents | 352.31M |
| Total Debt | 6.44M |
| Net Cash | 345.86M |
| Net Cash Per Share | $5.19 |
| Equity (Book Value) | 349.00M |
| Book Value Per Share | 5.24 |
| Working Capital | 344.43M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$60.07 million and capital expenditures -$314,000, giving a free cash flow of -$60.38 million.
| Operating Cash Flow | -60.07M |
| Capital Expenditures | -314,000 |
| Free Cash Flow | -60.38M |
| FCF Per Share | -$0.91 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FULC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.21% |
| Shareholder Yield | -2.21% |
| Earnings Yield | -13.76% |
| FCF Yield | -11.10% |
Analyst Forecast
The average price target for FULC is $16.38, which is 100.49% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.38 |
| Price Target Difference | 100.49% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |